1095336

Osiris Therapeutics Inc — FEI 3006638648

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 6, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Columbia, MD (United States)